Omega Funds
New York
Firm Location:New York • Massachusetts • Boston, Massachusetts • Cambridge, Massachusetts • London • Toronto, Ontario • Geneva • United Kingdom • Switzerland
Investor Firms That Co-Invest with Omega Funds
RA CapitalRoche Venture FundF-Prime Capital PartnersNovartis Venture FundSV Health InvestorsThe Column GroupAtlas VentureVida VenturesHatteras Venture PartnersPfizer Venture InvestmentsNew Enterprise Associates (NEA)Mott Family CapitalvenBioOsage University PartnersM Ventures (Merck)Cofounders CapitalCanaan Partners
Omega Funds Team
Investors in London
Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Pharmaceuticals (Series B), Investors in Health & Hospital Services (Series B), Investors in London (Other Lists), Investors in Digital Health (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Investors in United Kingdom
Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series B), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Investors in Cambridge (MA)
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in Health & Hospital Services (Series B), Investors in BioTech (Seed), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Boston / New England (Other Lists), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Digital Health (Series B), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Investors in Toronto (Ontario)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Pharmaceuticals (Series B), Investors in British Columbia (Other Lists), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in Digital Health (Series B), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Investors in Boston (MA)
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Boston / New England (Other Lists), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Digital Health (Series B), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Investors in Geneva
Investors in Consumer Health (Series A), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Investors in Massachusetts
Investors in BioTech (Seed), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Investors in New York
Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series B), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Investors in Massachusetts
Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series B), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Investors in Geneva
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series B), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Investors in Boston (MA)
Investors in Medical Devices (Seed), Investors in Consumer Health (Series B), Investors in Impact (Seed), Investors in BioTech (Series B), Investors in Consumer Health (Series A), Investors in Impact (Series B), Investors in Medical Devices (Series B), Investors in Impact (Series A), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in Impact (Seed), Investors in Health IT (Seed), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in Impact (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in Health & Hospital Services (Series A), Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Impact (Series B), Investors in Medical Devices (Series B), Investors in Health & Hospital Services (Series B), Investors in Boston / New England (Other Lists), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Digital Health (Series B), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series B), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)